Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

AVTXAVTX
8 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in AVALO THERAPEUTICS INC

RA CAPITAL MANAGEMENT, L.P. holds 1M shares of AVTX (AVALO THERAPEUTICS INC), worth $18.5M as of 2026-Q2. The position was increased (+50.8% shares). AVTX represents 0.2% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$18.5M

Current Shares

1M

Total Value Change

+$9.3M

Total Shares Change

+33,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+50.8%
$18.5M0.2%$18.48
47
2026-Q1
Unchanged
662,968
0.0%
$9.9M0.1%$18.85
0
2025-Q4
Unchanged
662,968
0.0%
$12M0.1%$17.81
0
2025-Q3
Decreased
662,968
-28.9%
$8.4M0.1%$13.02
0
2025-Q2
Decreased
932,973
-3.5%
$4.7M0.1%$4.78
0
2025-Q1
Unchanged
967,000
0.0%
$7.7M0.1%$8.46
0
2024-Q4
Unchanged
967,000
0.0%
$7.2M0.1%$7.80
0
2024-Q3
New
967,000
-
$9.2M0.1%$9.40
46

Other major holders of AVTX: FMR LLC, BlackRock, Inc., STATE STREET CORP, FARALLON CAPITAL MANAGEMENT, L.L.C., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used